A comparison of the pharmaceutical legislation of Kosovo with the requirements of european union

Authors

  • Fitim Alidema
  • Flakron Alidema
  • Arieta Hasani
  • Mirzade Krasniqi

DOI:

https://doi.org/10.55312/op.vi1.4387

Abstract

The importance of pharmaceutical legislation of a country consists in the establishment of rules, laws and other legislative acts according to which abides the work in health institutions emphasizing the pharmaceutical institutions ensues. Today’s structure of pharmaceutical legislation, as in laws for drugs, range of motion regarding the agencies of drug regulation, drug evaluation institutions, quality control among labs, drug informative centres has evolved with time.

Keywords:

Pharmaceutical legislation, European Union, Kosovo, Comparison.

Downloads

Download data is not yet available.

Author Biographies

Fitim Alidema

Universiteti i Prishtinës, Fakulteti i Mjekësisë, Katedra e Farmacisë

Flakron Alidema

Barnatorja Shëndetësore Private “ Fitimi Pharm” Pozheran, Kosovë

Arieta Hasani

Universiteti i Prishtinës, Fakulteti i Mjekësisë-QKUK-Neurologji

Mirzade Krasniqi

Barnatorja Shëndetësore Private “Fitimi Pharm” Pozheran, Kosovë

References

  1. Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu. Eff ective Drug Regulation: A multicountry study. World Health Organization 2002.

  2. Howells S. World Health Organization: international workshop on counterfeit drugs, Geneva, 26-28 November 1997 (abstract). (Document WHO/DRS/CFD/98.1).

  3. Adams C. FDA launches probe of drugs from overseas. Wall Street journal, 12 September 2000.

  4. World Health Organization. Eff ective drug regulation: what can countries do? (discussion paper). Geneva, WHO Essential Drugs and

  5. Medicines Programme, 1999 (Document WHO/ HTP/EDM/MAC(11)/99.6).

  6. Geiling E, Cannon P. Pathogenic eff ects of elixir of sulfanilamide (diethylene glycol) poisoning. A clinical and experimental correlation. Final report. Journal of the American Medical Association, 1938, 111:919-926.

  7. Dukes G. The eff ects of drug regulation: a survey based on the European studies of drug regulation. Lancaster, MTP Press Ltd., 1985.

  8. O’Brien KL et al. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Journal of the American Medical Association, 1998, 279(15):1175-78.

  9. Singh J et al. Diethylene glycol poisoning in Gurgaon, India, 1998. Bulletin of the World Health Organization, 2001, 79(2):88-95.

  10. Fake meningitis vaccine in Niger (editorial). Scrip, 23 August 1996, 2157:12.

  11. http://apps.who.int/medicinedocs/en/d/ Js2300e/17.html).

  12. REKOS2011 - Census preliminary results.

  13. Enti i Statistikave i Kosovës, 2011.

  14. IMF, 2010 projection.

  15. CIA World Factbook - Unless otherwise noted, information in this page is accurate as of July 12, 2011.

  16. PERINATAL SITUATION IN KOSOVO FOR YEARS 2000 – 2004.

  17. UNICEF. www.unicef.org/kosovo/children.html

  18. KIS/IOM/UNFPA, 1999.

  19. SA = Statistics Austria

  20. WHS – World Health Statistics

  21. World Bank 2005, burimet MEF, LSMS 2000, HBS 2002; MTEF 2008-2010; MLGA.

  22. Calculated for the NHA (National Health Accounts), 2008

  23. Aizhan Imasheva. Pharmaceutical sector of the Western Balkan countries. 2008 Annual Meeting & Exposition San Diego, CA October 25-29, 2008.

  24. Calculated for the NHA (National Health Accounts), 2007.

  25. Ministria e Shëndetësisë e Republikës së Kosovës. www.msh-ks.org/

  26. 2008 SPHS – Statistic Pharmacy Sector 2010.

  27. Agjencioni i Kosovës për Produkte Medicinale (AKPM). http://www.k-ma.org/

  28. 2008 WC – Written communication by Austrian ’ Assocition

  29. 2008 PHIS – PHIS Hospital Pharma Report 2009.

  30. WHS – World Health Statistics

  31. MSHP, Divizioni i Administrimit të pagesave dhe listpagesa e pagave. Marrë nga ESK 2008.

  32. 2010 WC – Written communication by Austrian Doctors’ Assocition

  33. Agjencia e Akreditimit e Kosoves (AAK), MSH.

  34. www.akreditimi-ks.org/

  35. Ruki Kondaj. Sfi dat e Farmaceutikës. Toena. Tiranë,

  36. Shqipëri, 2010; fq. 129, 130, 31, 139, 116.

Downloads

Published

2024-05-13

How to Cite

Alidema, F., Alidema, F., Hasani, A., & Krasniqi, M. (2024). A comparison of the pharmaceutical legislation of Kosovo with the requirements of european union. Optime, (1), 17–27. https://doi.org/10.55312/op.vi1.4387

Issue

No. 1 (2016): Optime

Section

Medical Sciences

Categories